Primary Purpose
| primary_purpose | Study_Count |
|---|---|
| Prevention | 579 |
| Treatment | 571 |
| Basic Science | 110 |
| Health Services Research | 89 |
| NA | 46 |
| Other | 45 |
| Supportive Care | 43 |
| Diagnostic | 35 |
| Screening | 10 |
| Device Feasibility | 3 |
Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD
See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG
To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html
| Type | Study_count |
|---|---|
| Total_Studies | 2643 |
| interventional | 1531 |
| Observational | 1050 |
| Registry | 62 |
```
| intervention_type | Study_Count |
|---|---|
| Behavioral | 390 |
| Drug | 260 |
| Other | 242 |
| Drug|placebo | 129 |
| Dietary Supplement | 115 |
| Device | 87 |
| Dietary Supplement|placebo | 56 |
| Procedure | 52 |
| Behavioral|Drug | 28 |
| Behavioral|Other | 23 |
| Drug|Procedure | 17 |
| Biological | 12 |
| Behavioral|Device | 9 |
| Diagnostic Test | 9 |
| Device|Other | 8 |
| Drug|Other | 8 |
| Other|placebo | 7 |
| Dietary Supplement|Other | 6 |
| Behavioral|Drug|placebo | 5 |
| Biological|placebo | 5 |
| Device|Drug | 5 |
| Device|Procedure | 4 |
| Dietary Supplement|Drug | 4 |
| Dietary Supplement|Drug|placebo | 4 |
| Dietary Supplement|Other|placebo | 4 |
| Behavioral|Dietary Supplement | 3 |
| Behavioral|Drug|Procedure | 3 |
| Behavioral|Procedure | 3 |
| Drug|Other|placebo | 3 |
| Genetic | 3 |
| Behavioral|Drug|Other | 2 |
| Biological|Procedure | 2 |
| Device|Drug|Procedure | 2 |
| Drug|placebo|Procedure | 2 |
| Other|Procedure | 2 |
| placebo | 2 |
| Behavioral|Device|Drug|Other|Procedure | 1 |
| Behavioral|Device|Other | 1 |
| Behavioral|Dietary Supplement|Other|placebo | 1 |
| Behavioral|placebo | 1 |
| Biological|Dietary Supplement|placebo | 1 |
| Biological|Other | 1 |
| Combination Product | 1 |
| Device|placebo | 1 |
| Diagnostic Test|Drug | 1 |
| Diagnostic Test|Drug|Procedure | 1 |
| Diagnostic Test|Other | 1 |
| Dietary Supplement|Drug|Other|placebo | 1 |
| Drug|Radiation | 1 |
| placebo|Procedure | 1 |
| Radiation | 1 |
| Country | Study_Count |
|---|---|
| United States | 603 |
| NA | 234 |
| United Kingdom | 95 |
| Canada | 88 |
| Netherlands | 38 |
| Denmark | 34 |
| China | 33 |
| Spain | 31 |
| France | 29 |
| Brazil | 26 |
| Norway | 22 |
| Germany | 18 |
| Italy | 18 |
| Korea, Republic of | 13 |
| Sweden | 12 |
| Australia | 11 |
| United States|Canada | 10 |
| Finland | 9 |
| India | 9 |
| Japan | 9 |
| Iran, Islamic Republic of | 8 |
| Mexico | 6 |
| Singapore | 6 |
| Switzerland | 6 |
| Taiwan | 6 |
| Belgium | 5 |
| Israel | 5 |
| Poland | 5 |
| Chile | 4 |
| Ireland | 4 |
| Russian Federation | 4 |
| Argentina | 3 |
| Turkey | 3 |
| Austria|Czechia|Germany|Hungary|Netherlands|Poland|Portugal|Spain|United Kingdom | 2 |
| Colombia | 2 |
| Czechia | 2 |
| Denmark|Finland|Iceland|Norway|Sweden | 2 |
| France|Germany|Italy | 2 |
| Ghana | 2 |
| Hong Kong | 2 |
| Malaysia | 2 |
| United States|Canada|Germany|Netherlands|United Kingdom | 2 |
| Argentina|Canada|India | 1 |
| Argentina|Czech Republic|Germany|Mexico|Poland|Romania|Russian Federation | 1 |
| Australia|Austria|Belgium|Brazil|Chile|Czech Republic|Denmark|Finland|France|Germany|Greece|Israel|Italy|Mexico|Netherlands|New Zealand|Poland|Portugal|Slovakia|South Africa|Spain|Sweden|Switzerland|United Kingdom|Venezuela | 1 |
| Australia|Estonia|Hungary|Latvia|Lithuania|New Zealand | 1 |
| Australia|India|Ireland|Netherlands|United Kingdom | 1 |
| Australia|United States|Argentina|Belgium|Canada|Colombia|Czechia|Estonia|France|Germany|Hungary|India|Israel|Luxembourg|Malaysia|Mexico|Netherlands|New Zealand|Norway|Poland|Russian Federation|Spain|Sweden|Ukraine|United Kingdom | 1 |
| Austria | 1 |
| Austria|Germany|New Zealand|Switzerland | 1 |
| Bangladesh | 1 |
| Bangladesh|Canada|Colombia|India|Malaysia|Philippines|Tanzania|Tunisia | 1 |
| Belgium|Denmark|France|Germany|Italy|Portugal|Sweden | 1 |
| Belgium|Germany|Sweden | 1 |
| Belgium|Ireland | 1 |
| Belgium|Netherlands | 1 |
| Canada|China | 1 |
| Canada|Colombia|Malaysia | 1 |
| Canada|Netherlands|Norway | 1 |
| Canada|Netherlands|Switzerland | 1 |
| China|Germany|Netherlands | 1 |
| China|India | 1 |
| China|India|Indonesia|Korea, Republic of|Malaysia|Philippines|Taiwan|Thailand|Vietnam | 1 |
| Croatia | 1 |
| Cyprus | 1 |
| Czechia|France|Germany|Hungary|Italy|Poland|Spain | 1 |
| Czechia|Germany | 1 |
| Denmark|Finland|Iceland|Netherlands|Norway|Sweden| | 1 |
| Denmark|Netherlands|Spain | 1 |
| Denmark|Norway|Sweden | 1 |
| Egypt | 1 |
| Estonia | 1 |
| France|Germany|New Zealand | 1 |
| Germany|Netherlands | 1 |
| Germany|United States|Australia|Brazil|Bulgaria|Canada|Czech Republic|Denmark|Estonia|Hungary|India|Israel|Lithuania|Malaysia|Mexico|Poland|Romania|Russian Federation|Slovakia|South Africa|Spain|Taiwan|Thailand|Ukraine|United Kingdom | 1 |
| Germany|United States|Canada|Denmark|Netherlands|Sweden|Switzerland | 1 |
| Greece | 1 |
| Indonesia | 1 |
| Ireland|Netherlands|United Kingdom | 1 |
| Italy|Netherlands|Spain|Switzerland | 1 |
| Jamaica | 1 |
| Kenya | 1 |
| Malawi | 1 |
| Mauritius | 1 |
| Netherlands|Norway|Poland|Switzerland | 1 |
| Netherlands|Spain | 1 |
| Netherlands|Sweden|United Kingdom | 1 |
| New Zealand|Norway|Poland|United States|Australia|Belgium|Canada|Czech Republic|Denmark|Finland|Germany|Hungary|Israel|Italy|Netherlands|Portugal|Spain|Sweden | 1 |
| Philippines | 1 |
| Poland|Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Denmark|France|Germany|India|Israel|Italy|Japan|Malaysia|Netherlands|New Zealand|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|United Kingdom | 1 |
| Poland|United States|Germany|Ireland|Italy|Puerto Rico|Spain|United Kingdom | 1 |
| Portugal | 1 |
| Romania | 1 |
| Slovakia | 1 |
| Spain|Taiwan | 1 |
| Spain|United States|Australia|Austria|Belgium|Canada|France|Germany|Ireland|Italy|Netherlands|South Africa|Switzerland|United Kingdom| | 1 |
| Sri Lanka | 1 |
| Thailand | 1 |
| Tunisia | 1 |
| United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|China|Colombia|Czechia|Denmark|Egypt|France|Germany|Greece|Guatemala|Hong Kong|Hungary|Iceland|India|Israel|Italy|Japan|Korea, Republic of|Lebanon|Malaysia|Mexico|Netherlands|Norway|Peru|Philippines|Poland|Portugal|Romania|Russian Federation|Slovakia|Slovenia|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|United Kingdom|Vietnam | 1 |
| United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|Czechia|Denmark|Estonia|Finland|France|Germany|Hong Kong|Hungary|India|Israel|Italy|Latvia|Lithuania|Mexico|Netherlands|Norway|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Slovakia|South Africa|Spain|Sweden|Switzerland|United Kingdom | 1 |
| United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|Colombia|Denmark|France|Germany|Hong Kong|India|Italy|Malaysia|New Zealand|Pakistan|Peru|South Africa|Spain|Switzerland|United Kingdom | 1 |
| United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Chile|Czech Republic|Denmark|Finland|France|Germany|Greece|Hong Kong|Hungary|Italy|Malaysia|Mexico|Netherlands|Norway|Poland|Portugal|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|United Kingdom | 1 |
| United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Egypt|France|Germany|Hungary|India|Israel|Italy|Japan|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|North Macedonia|Peru|Poland|Portugal|Romania|Russian Federation|Saudi Arabia|Serbia|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|United Kingdom | 1 |
| United States|Argentina|Australia|Austria|Bulgaria|Canada|Chile|Germany|Hungary|Poland | 1 |
| United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|China|Croatia|Czechia|Denmark|France|Greece|Hungary|Israel|Italy|Korea, Republic of|Poland|Romania|Singapore|Spain|Sweden|Taiwan|Ukraine|United Kingdom | 1 |
| United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|China|Croatia|Czechia|Denmark|France|Greece|Hungary|Israel|Italy|Korea, Republic of|Poland|Romania|Singapore|Spain|Taiwan|Ukraine|United Kingdom | 1 |
| United States|Argentina|Australia|Brazil|Bulgaria|Canada|Chile|Colombia|Czechia|Germany|Hungary|Korea, Republic of|Latvia|Lithuania|Mexico|New Zealand|Poland|Puerto Rico|Romania|Russian Federation|South Africa|Spain|Sweden|Taiwan|United Kingdom | 1 |
| United States|Argentina|Australia|Brazil|Canada|Czech Republic|Denmark|France|Germany|Greece|Korea, Republic of|Mexico|Netherlands|Taiwan|United Kingdom | 1 |
| United States|Argentina|Brazil|Canada|Georgia|Russian Federation | 1 |
| United States|Argentina|Canada|Germany|Romania|Slovakia|Spain|Taiwan|Vietnam | 1 |
| United States|Australia | 1 |
| United States|Australia|Austria|Canada|Germany|Greece|Ireland|Japan|United Kingdom | 1 |
| United States|Australia|Austria|Canada|Germany|Greece|Japan|United Kingdom | 1 |
| United States|Australia|Bahamas|Canada|Chile|Mexico|New Zealand|Poland | 1 |
| United States|Australia|Belgium|Canada|China|Czechia|Denmark|Estonia|Hungary|Italy|Japan|Korea, Republic of|Lithuania|Mexico|Netherlands|New Zealand|Poland|Russian Federation|South Africa|Taiwan|Ukraine|United Kingdom | 1 |
| United States|Australia|Belgium|Japan|United Kingdom | 1 |
| United States|Australia|Canada|China|Czech Republic|Denmark|France|Hungary|Mexico|Netherlands|Poland|Spain|United Kingdom | 1 |
| United States|Australia|Canada|India|Netherlands|New Zealand|Poland|Romania|Russian Federation|South Africa|Ukraine | 1 |
| United States|Austria|Mauritius | 1 |
| United States|Belgium | 1 |
| United States|Belgium|France|Germany|Ireland|Netherlands|Switzerland|United Kingdom | 1 |
| United States|Botswana|Brazil|Canada|Haiti|India|Peru|Puerto Rico|South Africa|Spain|Thailand|Uganda|Zimbabwe | 1 |
| United States|Brazil|Canada | 1 |
| United States|Canada|Argentina|Australia|Austria|Chile|Colombia|Czech Republic|Estonia|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Poland|Romania|Russian Federation|South Africa|Spain|Sweden|Thailand|United Kingdom | 1 |
| United States|Canada|China | 1 |
| United States|Canada|Czechia|Finland|France|Germany|Greece|Poland|Russian Federation|Slovakia|South Africa|United Kingdom | 1 |
| United States|Canada|Czechia|Germany|Poland|Romania | 1 |
| United States|Canada|Denmark|Germany|Netherlands | 1 |
| United States|Canada|France | 1 |
| United States|Canada|Germany|Netherlands|Poland|United Kingdom | 1 |
| United States|Canada|Germany|United Kingdom | 1 |
| United States|Canada|Puerto Rico | 1 |
| United States|China | 1 |
| United States|Colombia | 1 |
| United States|France|Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Czech Republic|Denmark|Finland|Germany|Greece|Hong Kong|Hungary|Ireland|Italy|Korea, Republic of|Malaysia|Mexico|Netherlands|New Zealand|Norway|Philippines|Poland|Portugal|Puerto Rico|Russian Federation|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Arab Emirates|United Kingdom | 1 |
| United States|France|Greece|Poland|United Kingdom | 1 |
| United States|Germany | 1 |
| United States|Germany|Greece|Italy|Netherlands|United Kingdom | 1 |
| United States|Germany|Israel|Italy|Netherlands|Spain|Switzerland | 1 |
| United States|Germany|Netherlands|New Zealand | 1 |
| United States|Mexico | 1 |
| United States|Peru|Argentina|Australia|Austria|Belgium|Bosnia and Herzegovina|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Czechia|Denmark|Estonia|Finland|France|Georgia|Germany|Greece|Guatemala|Hong Kong|Hungary|India|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Macedonia, The Former Yugoslav Republic of|Malaysia|Mexico|Netherlands|New Zealand|Norway|Philippines|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|Slovenia|South Africa|Spain|Sri Lanka|Sweden|Switzerland|Taiwan|Thailand|Turkey|Ukraine|United Kingdom | 1 |
| United States|Poland|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|Colombia|Croatia|Czechia|Denmark|Estonia|Germany|Hungary|India|Latvia|Lithuania|Mexico|Netherlands|New Zealand|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Turkey|Ukraine|United Kingdom | 1 |
| United States|Puerto Rico | 1 |
| United States|Spain|United Kingdom | 1 |
| United States|Taiwan | 1 |
| United States|United Kingdom | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 1202 |
| 2 | 100 |
| 3 | 43 |
| 4 | 27 |
| 5 | 17 |
| 6 | 13 |
| 7 | 6 |
| 8 | 6 |
| 9 | 9 |
| 10 | 4 |
| 11 | 1 |
| 12 | 2 |
| 13 | 5 |
| 14 | 3 |
| 15 | 3 |
| 16 | 5 |
| 17 | 2 |
| 18 | 2 |
| 19 | 1 |
| 20 | 2 |
| 21 | 1 |
| 22 | 1 |
| 23 | 1 |
| 24 | 3 |
| 25 | 1 |
| 28 | 3 |
| 29 | 1 |
| 30 | 2 |
| 31 | 3 |
| 32 | 2 |
| 34 | 1 |
| 35 | 1 |
| 37 | 1 |
| 38 | 1 |
| 39 | 2 |
| 40 | 2 |
| 45 | 1 |
| 47 | 1 |
| 49 | 1 |
| 52 | 1 |
| 53 | 1 |
| 54 | 3 |
| 55 | 1 |
| 56 | 1 |
| 58 | 2 |
| 67 | 3 |
| 69 | 1 |
| 75 | 1 |
| 80 | 1 |
| 82 | 1 |
| 90 | 1 |
| 104 | 1 |
| 113 | 1 |
| 126 | 1 |
| 127 | 1 |
| 130 | 2 |
| 133 | 1 |
| 135 | 1 |
| 137 | 1 |
| 141 | 1 |
| 145 | 1 |
| 194 | 1 |
| 203 | 1 |
| 241 | 1 |
| 270 | 1 |
| 288 | 1 |
| 301 | 1 |
| 313 | 1 |
| 314 | 1 |
| 320 | 1 |
| 388 | 1 |
| 393 | 1 |
| 410 | 1 |
| 466 | 1 |
| 470 | 1 |
| 499 | 1 |
| 630 | 1 |
| 732 | 1 |
| 754 | 1 |
| 788 | 1 |
| 1360 | 1 |
| 1388 | 1 |
| Phase | Study_Count |
|---|---|
| N/A | 914 |
| Phase 3 | 218 |
| Phase 4 | 143 |
| Phase 2 | 130 |
| Phase 1 | 79 |
| Phase 1/Phase 2 | 18 |
| Phase 2/Phase 3 | 18 |
| Early Phase 1 | 11 |
| Number_of_Arms | Count_of_Studies |
|---|---|
| 1 | 156 |
| 2 | 785 |
| 3 | 195 |
| 4 | 100 |
| 5 | 23 |
| 6 | 13 |
| 8 | 4 |
| 9 | 2 |
| 10 | 1 |
| 11 | 1 |
| 14 | 2 |
| 16 | 1 |
| 17 | 1 |
| NA | 247 |
| Measure | Early.Phase.1 | N.A | Phase.1 | Phase.1.Phase.2 | Phase.2 | Phase.2.Phase.3 | Phase.3 | Phase.4 |
|---|---|---|---|---|---|---|---|---|
| Min. | 4 | 2.000 | 1.00000 | 6.000 | 8.00 | 48.0000 | 18.00 | 8.000 |
| 1st Qu. | 23 | 41.000 | 16.00000 | 25.250 | 31.75 | 99.2500 | 152.00 | 45.000 |
| Median | 46 | 100.000 | 36.50000 | 47.000 | 70.00 | 265.0000 | 714.00 | 93.500 |
| Mean | 53 | 3021.729 | 54.16667 | 1143.111 | 231.93 | 513.7778 | 3601.97 | 1367.528 |
| 3rd Qu. | 70 | 300.000 | 60.00000 | 99.250 | 197.00 | 347.5000 | 3206.00 | 406.250 |
| Max. | 139 | 933789.000 | 448.00000 | 19500.000 | 8727.00 | 4110.0000 | 39876.00 | 31546.000 |
| group_type | Group_Count |
|---|---|
| Experimental | 1458 |
| Active Comparator | 782 |
| Placebo Comparator | 337 |
| No Intervention | 269 |
| NA | 247 |
| Other | 171 |
| Sham Comparator | 19 |
| intervention_model | Study_Count |
|---|---|
| Parallel Assignment | 892 |
| Crossover Assignment | 232 |
| Single Group Assignment | 207 |
| NA | 120 |
| Factorial Assignment | 68 |
| Sequential Assignment | 12 |
| primary_purpose | Study_Count |
|---|---|
| Prevention | 579 |
| Treatment | 571 |
| Basic Science | 110 |
| Health Services Research | 89 |
| NA | 46 |
| Other | 45 |
| Supportive Care | 43 |
| Diagnostic | 35 |
| Screening | 10 |
| Device Feasibility | 3 |
| Country | Study_Count |
|---|---|
| NA | 595 |
| United States | 191 |
| United Kingdom | 33 |
| Canada | 28 |
| China | 21 |
| France | 14 |
| Germany | 13 |
| Italy | 13 |
| Denmark | 11 |
| Netherlands | 10 |
| Sweden | 10 |
| Korea, Republic of | 9 |
| Taiwan | 9 |
| Switzerland | 8 |
| Norway | 7 |
| Brazil | 5 |
| Finland | 5 |
| Poland | 5 |
| Greece | 4 |
| Japan | 4 |
| Spain | 4 |
| Argentina | 3 |
| Israel | 3 |
| Russian Federation | 3 |
| United States|Canada | 3 |
| Austria | 2 |
| Belgium | 2 |
| Singapore | 2 |
| South Africa | 2 |
| Turkey | 2 |
| Algeria|Argentina|Australia|Brazil|China|Israel|Japan|Mexico|Saudi Arabia|Turkey | 1 |
| Argentina|Australia|Germany|Thailand | 1 |
| Argentina|Bangladesh|Brazil|Canada|Chile|China|Colombia|India|Iran, Islamic Republic of|Kazakhstan|Kyrgyzstan|Malaysia|Pakistan|Palestinian Territory, occupied|Peru|Philippines|Poland|Russian Federation|Saudi Arabia|South Africa|Sweden|Tanzania|Turkey|United Arab Emirates|Zimbabwe | 1 |
| Australia | 1 |
| Austria|Denmark|Finland|France|Germany|Italy|United Kingdom | 1 |
| Austria|Germany | 1 |
| Barbados|Puerto Rico|Trinidad and Tobago|Virgin Islands (U.S.) | 1 |
| Belgium|France|Germany|Italy|Switzerland | 1 |
| Belgium|France|Greece|Italy|Netherlands|Switzerland | 1 |
| Belgium|Germany|Italy|Switzerland | 1 |
| China|Hong Kong | 1 |
| Colombia|Mexico|Venezuela | 1 |
| India | 1 |
| Ireland | 1 |
| Italy|Netherlands|Spain | 1 |
| Malawi | 1 |
| Malaysia | 1 |
| Puerto Rico | 1 |
| Qatar | 1 |
| Slovenia | 1 |
| South Africa|Uganda | 1 |
| Uganda | 1 |
| United States|Argentina|Australia|Belgium|Canada|China|Colombia|Czechia|Denmark|Finland|France|Germany|Greece|Hungary|Iceland|Israel|Italy|Japan|Jordan|Kuwait|Malaysia|Mexico|Netherlands|New Zealand|Norway|Poland|Portugal|Puerto Rico|Russian Federation|Saudi Arabia|Serbia|Slovakia|Slovenia|South Africa|Spain|Sweden|Switzerland|United Arab Emirates|United Kingdom | 1 |
| United States|Argentina|Australia|Canada|China|Hong Kong|India|Korea, Republic of|Mexico|New Zealand|Singapore|Taiwan | 1 |
| United States|Australia|Belgium|Canada|Denmark|France|Germany|Hong Kong|Ireland|Italy|Netherlands|Spain|United Kingdom | 1 |
| United States|Austria|Canada|Germany|Italy|Korea, Republic of|Switzerland | 1 |
| United States|Canada|Egypt|Germany|Netherlands|Poland|Spain|United Kingdom | 1 |
| United States|Canada|France | 1 |
| United States|United Kingdom | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 949 |
| 2 | 31 |
| 3 | 8 |
| 4 | 12 |
| 5 | 4 |
| 6 | 5 |
| 7 | 4 |
| 8 | 4 |
| 10 | 3 |
| 11 | 2 |
| 12 | 3 |
| 13 | 1 |
| 14 | 1 |
| 15 | 1 |
| 17 | 1 |
| 20 | 3 |
| 22 | 1 |
| 28 | 1 |
| 29 | 1 |
| 33 | 1 |
| 34 | 1 |
| 36 | 2 |
| 39 | 1 |
| 43 | 1 |
| 44 | 1 |
| 49 | 1 |
| 56 | 1 |
| 66 | 1 |
| 88 | 1 |
| 104 | 1 |
| 165 | 1 |
| 302 | 1 |
| 334 | 1 |
| Measure | Observational |
|---|---|
| Min | 0.0 |
| 1st Qu | 140.5 |
| Median | 798.0 |
| Mean | 367019.9 |
| 3rd Qu | 4000.0 |
| Max | 99999999.0 |
| observational_model | Study_Count |
|---|---|
| NA | 498 |
| Cohort | 364 |
| Case-Control | 40 |
| Case-Only | 36 |
| Other | 35 |
| Case Control | 33 |
| Ecologic or Community | 20 |
| Family-Based | 11 |
| Case-Crossover | 4 |
| Defined Population, Natural History | 4 |
| Natural History | 4 |
| Case Control, Natural History | 1 |
| time_perspective | Study_Count |
|---|---|
| NA | 457 |
| Prospective | 375 |
| Cross-Sectional | 108 |
| Retrospective | 87 |
| Other | 17 |
| Cross-Sectional, Prospective | 2 |
| Longitudinal, Retrospective | 2 |
| Cross-Sectional, Retrospective/Prospective | 1 |
| Longitudinal, Prospective | 1 |
| Country | Study_Count |
|---|---|
| United States | 8 |
| NA | 7 |
| Spain | 5 |
| Netherlands | 4 |
| Italy | 3 |
| Canada | 2 |
| China | 2 |
| Denmark | 2 |
| Germany | 2 |
| Israel | 2 |
| Korea, Republic of | 2 |
| Poland | 2 |
| Turkey | 2 |
| Argentina | 1 |
| Austria | 1 |
| Austria|Czechia|Denmark|Germany|Israel|Italy|Kazakhstan|Netherlands|Poland|Singapore|United Kingdom | 1 |
| Austria|Germany | 1 |
| Austria|Germany|Ireland|Italy|Spain|Switzerland|Turkey|United Kingdom | 1 |
| Belgium|Finland|France|Germany|Greece|Italy|Netherlands|Portugal|Spain|Sweden|Switzerland|United Kingdom | 1 |
| Brazil | 1 |
| Czechia | 1 |
| France|Germany|Italy|Lithuania|Switzerland | 1 |
| Hungary | 1 |
| Japan | 1 |
| Netherlands|Poland|Spain|United Kingdom | 1 |
| Portugal|Argentina|Austria|Belarus|Belgium|Bosnia and Herzegovina|Croatia|Czechia|Denmark|Estonia|Finland|France|Georgia|Germany|Greece|Hungary|Iceland|Ireland|Israel|Italy|Latvia|Lithuania|Luxembourg|Netherlands|Norway|Poland|Romania|Russian Federation|Serbia|Slovakia|Slovenia|Spain|Sweden|Switzerland|Ukraine|United Kingdom | 1 |
| Qatar | 1 |
| Romania | 1 |
| Switzerland | 1 |
| Taiwan | 1 |
| United Kingdom | 1 |
| United States|Israel | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 43 |
| 2 | 4 |
| 3 | 3 |
| 5 | 1 |
| 7 | 1 |
| 9 | 1 |
| 14 | 1 |
| 16 | 1 |
| 20 | 1 |
| 22 | 1 |
| 26 | 1 |
| 36 | 1 |
| 37 | 1 |
| 51 | 1 |
| 110 | 1 |
| Measure | Registries |
|---|---|
| Min | 27 |
| 1st Qu | 400 |
| Median | 1200 |
| Mean | 209563 |
| 3rd Qu | 9500 |
| Max | 10000000 |
| observational_model | Study_Count |
|---|---|
| Cohort | 42 |
| Case-Only | 7 |
| Case-Control | 6 |
| Other | 6 |
| NA | 1 |
| time_perspective | Study_Count |
|---|---|
| Prospective | 45 |
| Cross-Sectional | 12 |
| Other | 4 |
| Retrospective | 1 |
| target_duration | Study_Count |
|---|---|
| 5 Years | 9 |
| 10 Years | 8 |
| 1 Year | 7 |
| 1 Day | 5 |
| 12 Months | 4 |
| 3 Years | 4 |
| 6 Months | 4 |
| 2 Years | 3 |
| 1 Week | 2 |
| 3 Months | 2 |
| 36 Months | 2 |
| 1 Month | 1 |
| 1020 Days | 1 |
| 20 Years | 1 |
| 24 Months | 1 |
| 3 Days | 1 |
| 30 Days | 1 |
| 30 Years | 1 |
| 4 Weeks | 1 |
| 4 Years | 1 |
| 6 Years | 1 |
| 7 Years | 1 |
| 88 Months | 1 |
#If less then 500 trials
#If less then 500 studies
#If less then 500 registries
| nct_id | brief_title | link | overall_status | source | primary_completion_date |
|---|---|---|---|---|---|
| NCT03139006 | Application of speCtraL Computed tomogrAphy to impRove specIficity of Cardiac compuTed tomographY | https://ClinicalTrials.gov/show/NCT03139006 | Recruiting | UMC Utrecht | 2021-03-29 |
| NCT04298307 | Registry of Coronary Lithotripsy in Spain. | https://ClinicalTrials.gov/show/NCT04298307 | Recruiting | Fundación EPIC | 2022-06-01 |
| NCT03294369 | Cardiovascular Risk in Toledo Population | https://ClinicalTrials.gov/show/NCT03294369 | Recruiting | Castilla-La Mancha Health Service | 2020-12-31 |
| NCT03293758 | Food and Microbiome Longitudinal Investigation (FAMiLI) | https://ClinicalTrials.gov/show/NCT03293758 | Recruiting | NYU Langone Health | 2021-05-16 |
| NCT03191227 | The Cork and Kerry Diabetes and Heart Disease Study (Phase II) Mitchelstown Cohort | https://ClinicalTrials.gov/show/NCT03191227 | Completed | University College Cork | 2011-05-31 |
| NCT03172507 | The Role of Stem Cells on Immune Cells in the Development of Cardiovascular Diseases | https://ClinicalTrials.gov/show/NCT03172507 | Completed | Radboud University | 2018-08-31 |
| NCT03005834 | The Sakakibara Health Integrative Profile Cohort Study | https://ClinicalTrials.gov/show/NCT03005834 | Completed | Sakakibara Heart Institute | 2014-07-31 |
| NCT02922088 | EU Multicenter Registry to Assess Outcomes in CABG Patients: Treatment of Vascular Conduits With DuraGraft [VASC] | https://ClinicalTrials.gov/show/NCT02922088 | Active, not recruiting | Somahlution LLC | 2024-08-31 |
| NCT02913144 | 7 Year Follow-up Study of the DanRisk Population | https://ClinicalTrials.gov/show/NCT02913144 | Completed | Odense University Hospital | 2015-06-30 |
| NCT02889653 | The Bleeding With Antithrombotic Therapy Study 2 | https://ClinicalTrials.gov/show/NCT02889653 | Recruiting | National Cerebral and Cardiovascular Center | 2020-03-31 |
| NCT02863211 | The Assessment of Large and Small Artery Elasticity for the Early Detection of Cardiovascular Disease | https://ClinicalTrials.gov/show/NCT02863211 | Active, not recruiting | St. Boniface General Hospital Research Centre | 2022-02-28 |
| NCT02699736 | EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV | https://ClinicalTrials.gov/show/NCT02699736 | Enrolling by invitation | Rigshospitalet, Denmark | 2030-12-31 |
| NCT02674230 | OCEAN Registry: Obesity and Clock for Elegant Aging Registry | https://ClinicalTrials.gov/show/NCT02674230 | Recruiting | Chang Gung Memorial Hospital | 2026-06-30 |
| NCT02640859 | Investigation of Metabolic Risk in Korean Adults | https://ClinicalTrials.gov/show/NCT02640859 | Completed | Seoul National University Bundang Hospital | 2018-11-30 |
| NCT03387384 | Appropriateness of Aspirin Use in Medical Outpatients | https://ClinicalTrials.gov/show/NCT03387384 | Recruiting | Muğla Sıtkı Koçman University | 2019-06-30 |
| NCT02497950 | HeartMate 3 ELEVATEâ„¢ | https://ClinicalTrials.gov/show/NCT02497950 | Active, not recruiting | Abbott Medical Devices | 2019-02-28 |
| NCT02347982 | Epidemiology of Cardiovascular Disease in Elderly Turkish Population | https://ClinicalTrials.gov/show/NCT02347982 | Completed | Turkish Society of Cardiology | 2015-12-31 |
| NCT02341664 | Patient and Provider Assessment of Lipid Management Registry | https://ClinicalTrials.gov/show/NCT02341664 | Completed | Duke University | 2016-02-29 |
| NCT02294500 | Cohort Study to Evaluate Ovarian Function | https://ClinicalTrials.gov/show/NCT02294500 | Recruiting | Huazhong University of Science and Technology | 2016-05-31 |
| NCT02224222 | Assessment of Frailty as a Risk Factor for Cardiac and Vascular Surgery | https://ClinicalTrials.gov/show/NCT02224222 | Active, not recruiting | Semmelweis University Heart and Vascular Center | 2020-04-30 |
| NCT02070926 | The CRONOS-ADM Registry | https://ClinicalTrials.gov/show/NCT02070926 | Completed | Seoul St. Mary’s Hospital | 2010-12-31 |
| NCT02038491 | RICALOR Italian Registry for Complications During Regional Anesthesia | https://ClinicalTrials.gov/show/NCT02038491 | Completed | IRCCS Policlinico S. Matteo | 2009-05-31 |
| NCT02015832 | A Trial to Evaluate a New Strategy in the Functional Assessment of 3-vessel Disease Using the SYNTAX II Score in Patients Treated With PCI | https://ClinicalTrials.gov/show/NCT02015832 | Active, not recruiting | ECRI bv | 2017-03-28 |
| NCT02000895 | Early Detection of Progressive Kidney Disease in Preterm Infants | https://ClinicalTrials.gov/show/NCT02000895 | Recruiting | University of Miami | 2024-08-31 |
| NCT04451356 | Romanian Kidney Transplant Cardiovascular Risk Registry | https://ClinicalTrials.gov/show/NCT04451356 | Recruiting | Grigore T. Popa University of Medicine and Pharmacy | 2022-12-31 |
| NCT01917682 | Post-Market CorPath Registry on the CorPath 200 System in Percutaneous Coronary Interventions | https://ClinicalTrials.gov/show/NCT01917682 | Completed | Corindus Inc. | 2016-12-31 |
| NCT01897220 | Perioperative Ischemia Versus Perioperative Bleeding During Non-cardiac Surgery in Cardiac Patients | https://ClinicalTrials.gov/show/NCT01897220 | Completed | Charles University, Czech Republic | 2013-06-30 |
| NCT01804439 | Risk Factors in the Initial Presentation of Specific Cardiovascular Disease Syndromes | https://ClinicalTrials.gov/show/NCT01804439 | Completed | University College, London | 2010-03-31 |
| NCT01784055 | NeoChord TACT Post-Market Surveillance Registry | https://ClinicalTrials.gov/show/NCT01784055 | Completed | NeoChord | 2016-07-31 |
| NCT01761669 | Does Deficiency in Vitamin D Induced Hypercoagulation or Thrombin Generation | https://ClinicalTrials.gov/show/NCT01761669 | Completed | HaEmek Medical Center, Israel | 2013-06-30 |
| NCT01759225 | Registry of Cardiovascular Disease Patients | https://ClinicalTrials.gov/show/NCT01759225 | Enrolling by invitation | Maccabi Healthcare Services, Israel | 2100-12-31 |
| NCT04442334 | The European NAFLD Registry | https://ClinicalTrials.gov/show/NCT04442334 | Recruiting | Newcastle University | 2030-12-31 |
| NCT04430374 | Registry for a Cardiovascular Patient Who COVID-19 Infection in Qatar and Gulf | https://ClinicalTrials.gov/show/NCT04430374 | Recruiting | Hamad Medical Corporation | 2020-12-31 |
| NCT04390555 | The Global PCHF-COVICAV Registry | https://ClinicalTrials.gov/show/NCT04390555 | Recruiting | University of Zurich | 2020-12-31 |
| NCT04374110 | Drug Safety and the Occurrence of Complications During Hospitalization in Patients With COVID-19 | https://ClinicalTrials.gov/show/NCT04374110 | Recruiting | Institute of Cardiology, Warsaw, Poland | 2020-06-24 |
| NCT04359927 | Long-term Effects of Coronavirus Disease 2019 on the Cardiovascular System: CV COVID-19 Registry | https://ClinicalTrials.gov/show/NCT04359927 | Recruiting | Hospital Clinic of Barcelona | 2021-08-31 |
| NCT04353232 | Relation Between Accumulated Air Pollution Exposure and Subclinical Cardiovascular Disease | https://ClinicalTrials.gov/show/NCT04353232 | Recruiting | Odense University Hospital | 2020-09-01 |
| NCT04331574 | Renin-Angiotensin System Inhibitors and COVID-19 | https://ClinicalTrials.gov/show/NCT04331574 | Recruiting | Societa Italiana dell’Ipertensione Arteriosa | 2020-04-10 |
| NCT04327479 | Characterization of Cardiovascular Diseases and Risk Factors in Patients With Suspected SARS-CoV2/Covid-19 Infection | https://ClinicalTrials.gov/show/NCT04327479 | Recruiting | University Hospital, Essen | 2026-03-25 |
| NCT04325412 | Cardiac complicAtions in Patients With SARS Corona vIrus 2 regisTrY | https://ClinicalTrials.gov/show/NCT04325412 | Recruiting | UMC Utrecht | 2021-03-23 |
| NCT04281823 | DeBakey Cardiovascular Magnetic Resonance Study | https://ClinicalTrials.gov/show/NCT04281823 | Recruiting | The Methodist Hospital System | 2058-04-01 |
| NCT04256720 | The Multi-Ethnic Lifestyle Study | https://ClinicalTrials.gov/show/NCT04256720 | Recruiting | University of Leicester | 2023-11-01 |
| NCT04199663 | Socioeconomic Status, Secondary Prevention Activities and Recurrence After a Myocardial Infarction | https://ClinicalTrials.gov/show/NCT04199663 | Completed | Karolinska Institutet | 2018-12-31 |
| NCT04172064 | Myocardial Perfusion and Contractile Reserve in End-stage Renal Disease | https://ClinicalTrials.gov/show/NCT04172064 | Completed | University Hospital Muenster | 2013-06-30 |
| NCT04146701 | Metabolomics and Microbiomics in Cardiovascular Diseases Mannheim | https://ClinicalTrials.gov/show/NCT04146701 | Recruiting | Universitätsmedizin Mannheim | 2019-12-01 |
| NCT04136392 | The Global cVAD Study | https://ClinicalTrials.gov/show/NCT04136392 | Active, not recruiting | Abiomed Inc. | 2025-01-31 |
| NCT04087356 | Age-related Macular Degeneration (AMD) and Cardiovascular Disease | https://ClinicalTrials.gov/show/NCT04087356 | Recruiting | The New York Eye & Ear Infirmary | 2020-01-31 |
| NCT04040777 | Cardiometabolic Risk Factors Registry | https://ClinicalTrials.gov/show/NCT04040777 | Recruiting | Austral University, Argentina | 2020-12-31 |
| NCT04030286 | Evaluation of Malondialdehyde in Periodontal and Cardiovascular Disease | https://ClinicalTrials.gov/show/NCT04030286 | Completed | University of Messina | 2018-09-09 |
| NCT04017663 | Publicly Versus Privately-Funded Cardiac Rehabilitation | https://ClinicalTrials.gov/show/NCT04017663 | Completed | Universidade Estadual Paulista Júlio de Mesquita Filho | 2018-08-10 |
| NCT03963271 | Noninvasive Electrocardiographic Imaging for Individuals at Risk for Apparently Idiopathic Ventricular Fibrillation. | https://ClinicalTrials.gov/show/NCT03963271 | Enrolling by invitation | Maastricht University Medical Center | 2023-04-10 |
| NCT03949829 | The CoPenHagen PREeClampsia and cardIOvascUlar diSease Trial | https://ClinicalTrials.gov/show/NCT03949829 | Enrolling by invitation | Rigshospitalet, Denmark | 2021-06-30 |
| NCT03938155 | Women’s Advanced Risk-assessment in Manitoba | https://ClinicalTrials.gov/show/NCT03938155 | Recruiting | St. Boniface General Hospital Research Centre | 2021-10-01 |
| NCT03818724 | Treatment Success With the CoolLoop Cryoablation System | https://ClinicalTrials.gov/show/NCT03818724 | Recruiting | AFreeze GmbH | 2025-01-31 |
| NCT03736226 | A Post-Approval, Single-Arm Study of the SYNERGY Stent System in China | https://ClinicalTrials.gov/show/NCT03736226 | Recruiting | Boston Scientific Corporation | 2021-12-31 |
| NCT03616418 | Ankle Brachial Index Combined With Serum Uric Acid Levels Improve Prediction All Cause Mortality and Cardiovascular Mortality in the Elderly Chinese Population | https://ClinicalTrials.gov/show/NCT03616418 | Enrolling by invitation | Shanghai 10th People’s Hospital | 2019-08-01 |
| NCT03513926 | Molecular Profile of Cardiovascular Risk in Obstructive Sleep Apnea Patients: Personalized Predictive Model. | https://ClinicalTrials.gov/show/NCT03513926 | Completed | Sociedad Española de NeumologÃa y CirugÃa Torácica | 2018-01-31 |
| NCT03463486 | Current Outpatient Cardiac Rehabilitation in Austria | https://ClinicalTrials.gov/show/NCT03463486 | Active, not recruiting | Paracelsus Medical University | 2018-12-31 |
| NCT03446794 | Left Atrial Appendage Occlusion With WATCHMAN® Device in Patients With Non-valvular Atrial Fibrillation and End-stage Chronic Kidney Disease on Hemodialysis | https://ClinicalTrials.gov/show/NCT03446794 | Recruiting | Fundación EPIC | 2021-03-01 |
| NCT03898570 | Distributed Registry | https://ClinicalTrials.gov/show/NCT03898570 | Recruiting | Stanford University | 2019-09-30 |
| NCT02743533 | Cardiovascular Diseases in the Silesian Region in Poland. | https://ClinicalTrials.gov/show/NCT02743533 | Recruiting | Silesian Centre for Heart Diseases | 2020-12-31 |
| NCT02219269 | A Complex Contraception Registry | https://ClinicalTrials.gov/show/NCT02219269 | Completed | University of California, San Diego | 2015-06-30 |